Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin L Kårhus

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|August 10, 2024
Comment on Yang et al. Bile Acid Diarrhea: From Molecular Mechanisms to Clinical Diagnosis and Treatment in the Era of Precision Medicine. <i>Int. J. Mol. Sci.</i> 2024, <i>25</i>, 1544Anne-Marie Ellegaard, Martin L Kårhus, Filip K Knop
Diabetes, Obesity & Metabolism|March 18, 2017
Evidence connecting old, new and neglected glucose-lowering drugs to bile acid-induced GLP-1 secretion: A reviewMartin L Kårhus, Andreas Brønden, David P Sonne, et al.
Clinical and Translational Gastroenterology|January 14, 2025
Treatment of Bile Acid Diarrhea With Glucagon-Like Peptide 1 Receptor Agonists: A Promising Yet Understudied ApproachAnne-Marie Ellegaard, Martin L Kårhus, Matilde Winther-Jensen, et al.
The American Journal of Gastroenterology|May 8, 2024
Bile Acid Diarrhea Is Associated With an Increased Incidence of Gastrointestinal CancersAnne-Marie Ellegaard, Martin L Kårhus, Matilde Winther-Jensen, et al.
Clinical and Translational Gastroenterology|May 23, 2025
Bile Acid Diarrhea Is Associated With an Increased Risk of Type 2 Diabetes and Cardiovascular Disease: A Nationwide Cohort StudyAnne-Marie Ellegaard, Matilde Winther-Jensen, Line L Kårhus, et al.
Clinical Epidemiology|December 13, 2023
The Epidemiology of Bile Acid Diarrhea in DenmarkMartin L Kårhus, Anne-Marie Ellegaard, Matilde Winther-Jensen, et al.
Clinical and Translational Gastroenterology|November 27, 2024
Liraglutide and Colesevelam Change Serum and Fecal Bile Acid Levels in a Randomized Trial With Patients With Bile Acid DiarrheaAnne-Marie Ellegaard, Martin L Kårhus, Lukasz Krych, et al.
The Lancet. Gastroenterology & Hepatology|July 22, 2022
Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trialMartin L Kårhus, Andreas Brønden, Julie L Forman, et al.
Gastro Hep Advances|August 12, 2024
Enterohepatic, Gluco-metabolic, and Gut Microbial Characterization of Individuals With Bile Acid MalabsorptionMartin L Kårhus, David P Sonne, Martin Thomasen, et al.
Endocrine Connections|February 25, 2026
Metabolic, enterohepatic and gut microbial effects of atorvastatin in healthy menMartin Thomasen, Maria-Anna Misiakou, Simone S Li, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|August 10, 2024
Comment on Yang et al. Bile Acid Diarrhea: From Molecular Mechanisms to Clinical Diagnosis and Treatment in the Era of Precision Medicine. <i>Int. J. Mol. Sci.</i> 2024, <i>25</i>, 1544Anne-Marie Ellegaard, Martin L Kårhus, Filip K Knop
Diabetes, Obesity & Metabolism|March 18, 2017
Evidence connecting old, new and neglected glucose-lowering drugs to bile acid-induced GLP-1 secretion: A reviewMartin L Kårhus, Andreas Brønden, David P Sonne, et al.
Clinical and Translational Gastroenterology|January 14, 2025
Treatment of Bile Acid Diarrhea With Glucagon-Like Peptide 1 Receptor Agonists: A Promising Yet Understudied ApproachAnne-Marie Ellegaard, Martin L Kårhus, Matilde Winther-Jensen, et al.
The American Journal of Gastroenterology|May 8, 2024
Bile Acid Diarrhea Is Associated With an Increased Incidence of Gastrointestinal CancersAnne-Marie Ellegaard, Martin L Kårhus, Matilde Winther-Jensen, et al.
Clinical and Translational Gastroenterology|May 23, 2025
Bile Acid Diarrhea Is Associated With an Increased Risk of Type 2 Diabetes and Cardiovascular Disease: A Nationwide Cohort StudyAnne-Marie Ellegaard, Matilde Winther-Jensen, Line L Kårhus, et al.
Clinical Epidemiology|December 13, 2023
The Epidemiology of Bile Acid Diarrhea in DenmarkMartin L Kårhus, Anne-Marie Ellegaard, Matilde Winther-Jensen, et al.
Clinical and Translational Gastroenterology|November 27, 2024
Liraglutide and Colesevelam Change Serum and Fecal Bile Acid Levels in a Randomized Trial With Patients With Bile Acid DiarrheaAnne-Marie Ellegaard, Martin L Kårhus, Lukasz Krych, et al.
The Lancet. Gastroenterology & Hepatology|July 22, 2022
Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trialMartin L Kårhus, Andreas Brønden, Julie L Forman, et al.
Gastro Hep Advances|August 12, 2024
Enterohepatic, Gluco-metabolic, and Gut Microbial Characterization of Individuals With Bile Acid MalabsorptionMartin L Kårhus, David P Sonne, Martin Thomasen, et al.
Endocrine Connections|February 25, 2026
Metabolic, enterohepatic and gut microbial effects of atorvastatin in healthy menMartin Thomasen, Maria-Anna Misiakou, Simone S Li, et al.
Pageof 1